Deutsche Bank’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Buy
+53,312
New +$249K ﹤0.01% 3205
2021
Q3
Sell
-1,400
Closed -$7K 4719
2021
Q2
$7K Buy
+1,400
New +$6.95K ﹤0.01% 4490
2020
Q1
Sell
-375
Closed -$2K 4900
2019
Q4
$2K Buy
+375
New +$2.83K ﹤0.01% 4859
2017
Q3
Sell
-35
Closed -$4K 5119
2017
Q2
$4K Buy
+35
New +$6.8K ﹤0.01% 4784
2015
Q2
Sell
-10
Closed -$3K 5491
2015
Q1
$3K Sell
10
-82
-89% -$29.8K ﹤0.01% 4960
2014
Q4
$30K Sell
92
-127
-58% -$43.9K ﹤0.01% 5375
2014
Q3
$85K Buy
219
+6
+3% +$2.16K ﹤0.01% 4604
2014
Q2
$88K Buy
+213
New +$96.8K ﹤0.01% 4640

Other funds holding IRD

Deutsche Bank's IRD Position: Q2 2026 in Review

Deutsche Bank opened a new position in Opus Genetics (IRD) in Q2 2026: 53,312 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #3205 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in IRD as recently as Q2 2021.

Deutsche Bank first reported a position in IRD in Q2 2014 and has held it in 8 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Deutsche Bank held 53,312 shares of Opus Genetics worth $219K as of Q2 2026.
  • Opus Genetics was a new Deutsche Bank position in Q2 2026.
  • Opus Genetics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3205 holding.
  • Deutsche Bank first reported a position in Opus Genetics in Q2 2014 and has held it in 8 quarters since.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.